A Derlon

704 total citations
28 papers, 444 citations indexed

About

A Derlon is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, A Derlon has authored 28 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Surgery and 5 papers in Genetics. Recurrent topics in A Derlon's work include Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). A Derlon is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). A Derlon collaborates with scholars based in France, United States and Canada. A Derlon's co-authors include Joanne Guay, Kamran Samii, Charles Marc Samama, Patrick Mismetti, Silvy Laporte, Gérald Simonneau, N. Nathan, A. Steib, Brigitte Ickx and Philippe de Moerloose and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

A Derlon

26 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Derlon France 13 235 180 138 104 47 28 444
Patsy Vegh Canada 9 328 1.4× 71 0.4× 153 1.1× 76 0.7× 9 0.2× 11 434
Surabhi Palkimas United States 11 120 0.5× 86 0.5× 174 1.3× 171 1.6× 27 0.6× 25 366
Peter Cooper United Kingdom 12 484 2.1× 69 0.4× 255 1.8× 137 1.3× 9 0.2× 16 592
Elisabetta Favaretto Italy 15 116 0.5× 210 1.2× 334 2.4× 176 1.7× 4 0.1× 30 496
L. Scarano Italy 13 323 1.4× 185 1.0× 366 2.7× 173 1.7× 4 0.1× 22 626
Jean‐Pierre Carteaux France 13 77 0.3× 201 1.1× 56 0.4× 212 2.0× 19 0.4× 34 465
Samantha Pasca Italy 13 291 1.2× 54 0.3× 136 1.0× 105 1.0× 3 0.1× 48 486
Mohammad Malik United States 8 290 1.2× 474 2.6× 177 1.3× 157 1.5× 6 0.1× 13 556
Annette Bowyer United Kingdom 17 642 2.7× 118 0.7× 82 0.6× 132 1.3× 7 0.1× 39 795
Edith Peynaud-Debayle France 10 292 1.2× 303 1.7× 181 1.3× 77 0.7× 2 0.0× 18 500

Countries citing papers authored by A Derlon

Since Specialization
Citations

This map shows the geographic impact of A Derlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Derlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Derlon more than expected).

Fields of papers citing papers by A Derlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Derlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Derlon. The network helps show where A Derlon may publish in the future.

Co-authorship network of co-authors of A Derlon

This figure shows the co-authorship network connecting the top 25 collaborators of A Derlon. A scholar is included among the top collaborators of A Derlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Derlon. A Derlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ettingshausen, Carmen Escuriola, Όλγα Κατσαρού, Barbara Faganel Kotnik, et al.. (2021). Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study. Haemophilia. 28(1). 46–54. 2 indexed citations
2.
Lambert, Thierry, C Guérois, Natalie Stieltjes, et al.. (2007). Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients. Haemophilia. 13(4). 357–360. 8 indexed citations
3.
Simonneau, Gérald, Silvy Laporte, Patrick Mismetti, et al.. (2006). A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer. Journal of Thrombosis and Haemostasis. 4(8). 1693–1700. 67 indexed citations
4.
Gruel, Yves, Claire Pouplard, Philippe Nguyên, et al.. (2003). Biological and clinical features of low‐molecular‐weight heparin‐induced thrombocytopenia. British Journal of Haematology. 121(5). 786–792. 65 indexed citations
5.
Ozier, Yves, A. Steib, Brigitte Ickx, et al.. (2001). Haemostatic disorders during liver transplantation. European Journal of Anaesthesiology. 18(4). 208–218. 32 indexed citations
6.
Ozier, Yves, A. Steib, Brigitte Ickx, et al.. (2001). Haemostatic disorders during liver transplantation. European Journal of Anaesthesiology. 18(4). 208–218. 28 indexed citations
8.
Lefrançois, C, A Derlon, Philippe Gautier, et al.. (1994). Thromboses veineuses mésentériques. Facteurs de risque, traitement et évolution. Analyse de 18 observations. Annales Françaises d Anesthésie et de Réanimation. 13(2). 182–194. 14 indexed citations
9.
Ribba, Anne‐Sophie, Olivier D. Christophe, A Derlon, et al.. (1994). Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease. Blood. 83(3). 833–841. 4 indexed citations
10.
Verroust, F., M.‐F. Torchet, E Fressinaud, et al.. (1993). Comparison of Anti-Human and Anti-Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia A. Vox Sanguinis. 64(4). 210–214. 14 indexed citations
11.
Hourdillé, P, HR Gralnick, E Heilmann, et al.. (1992). von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Blood. 79(8). 2011–2021. 1 indexed citations
12.
Hourdillé, P, HR Gralnick, E Heilmann, et al.. (1992). von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Blood. 79(8). 2011–2021. 33 indexed citations
13.
Tartière, Jean‐Michel, et al.. (1992). [Changes in coagulation factor VIII after liver transplantation in a patient with hemophilia A].. PubMed. 21(5). 216–216. 2 indexed citations
15.
Lefrançois, C, et al.. (1991). [Type II protein S deficiency. Role in the occurrence of arteriovenous thrombosis of the mesocolon].. PubMed. 20(41). 2106–2106. 1 indexed citations
16.
Lefrançois, C, et al.. (1990). Les déficits constitutionnels en antithrombine III, protéine C et protéine S. Etude de 31 sujets appartenant à huit familles non apparentées. Annales Françaises d Anesthésie et de Réanimation. 9(6). 485–494. 4 indexed citations
18.
Aiach, Martine, Fiessinger Jn, A Derlon, et al.. (1989). [Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].. PubMed. 10(4). 375–81. 15 indexed citations
19.
Derlon, A, et al.. (1987). [Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)].. PubMed. 12 Suppl B. 99–101. 1 indexed citations
20.
Derlon, A, et al.. (1986). Pentosane polysulfate like heparin may induce severe thrombocytopenia. Thrombosis Research. 41. 90–90.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026